Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2024)

Bright Minds Biosciences' (DRUG) quarterly EPS (Basic) came in at $0.01 in Q4 2024, up 101.79% YoY from $0.0 in Q1 2024, and down 84.7% on a QoQ basis from $0.04 in Q2 2024.

Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2024) Analysis & Trends

Bright Minds Biosciences (DRUG) has 2 years of EPS (Basic) data on file, last reported at $0.01 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Bright Minds Biosciences 733.05 Mn 733.05 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.01
Jun 30, 2024 0.04
Dec 31, 2023 -0.32
Jun 30, 2023 -0.29